GENE Prakiraan wutah bathi resik saben saham ing taun iki GTG Labs
Slow adoption rates of genetic tests and the risk of share dilution due to secondary offerings are weighing on Genetic Technologies (GENE). Growth depends on the clinical validation of methodologies and laboratory throughput. The company generates capital through preventive diagnostics for cancer and diabetes. The annual earnings per share trend on GURU.Markets reflects a dynamic where the indicator remains around 0.00.
Rincian metrik keuangan lan pasar gtglabs.com (GENE)
- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi pasar:
- data nilai buku modal saham:
- indikator beban utang lan likuiditas:
Rasio Utang marang Ekuitas Genetic Technologies|GENE - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Genetic Technologies Limited|GENE - Gunggung utang perusahaan|Utang marang modal buku Genetic Technologies Limited|GENE - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Genetic Technologies|Indikator likuiditas cepet gtglabs.com
- data bathi bisnis lan rasio investasi:
GENE - Penghasilan resik|Penghasilan resik sing dikarepake Genetic Technologies|GENE - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Genetic Technologies Limited|GENE - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Genetic Technologies Limited|GENE - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Genetic Technologies|GENE - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan gtglabs.com|GENE - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Genetic Technologies
Ringkesan analisis perusahaan:GTG Labs - GENE
For Genetic Technologies (GENE), which lacks stable revenue streams, profit dynamics depend critically on the commercial success of its oncology tests. By analyzing year-over-year EPS growth rates, an investor can observe the percentage change in net income per share relative to the previous year, adjusted for seasonality. A negative trajectory for this indicator signals a risk of capital freeze due to weak operational liquidity.
Pesaing langsung
A - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Quest|Illumina Platform (ILMN) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku EXAS|revvity.com (RVTY) - Owah-owahan bathi resik saben saham ing taun lumaku|Wutah bathi ing taun lumaku BIO (Bio-Rad)|Anbio Biotechnology Ltd (NNNN) - Kacepetan wutah bathi saben saham ing taun lumaku|SHC - Wutah bathi saben saham ing taun lumaku|QDEL (QuidelOrtho Inc.) - Wutah bathi saben saham ing taun iki|OPK: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku CareDx (CDNA)|Wutah bathi resik saben saham ing taun iki MRVI|FLGT (Fulgent Genetics Inc) - Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi ing taun lumaku LAB|Prakiraan wutah bathi resik saben saham ing taun iki Cytek Corp|Wutah bathi ing taun lumaku OSUR (OraSure Technologies)|XGN - Wutah bathi resik saben saham ing taun iki|MDXH: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku LUCD (Lucid Diagnostics, Inc.)|PRE (prenetics.com) - Wutah bathi resik saben saham ing taun iki|IMDX: Wutah bathi resik saben siji saham kanggo taun lumaku|TRIB (Trinity Biotech PLC) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku prophaselabs.com PRPH|Wutah bathi ing taun lumaku AIMD|Wutah bathi resik saben saham ing taun iki Co-Diagnostics Inc CODX|Wutah bathi ing taun lumaku HSCS (Heart Test Laboratories Inc.)|Tambahing bathi saben saham ing taun lumaku BMRA|CDIO - Wutah bathi saben saham ing taun lumaku|ONCO (onconetix.gcs-web.com) - Wutah bathi saben saham ing taun iki|Virax Biolabs (VRAX) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Bluejay Diagnostics Inc (BJDX)|Wutah bathi saben saham ing taun lumaku Vermillion|Wutah bathi saben saham ing taun lumaku AXDX|Wutah bathi saben saham ing taun lumaku Centogene NV (CNTG)|ENZ - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku FRES (Fresh2 Group)|Owah-owahan bathi resik saben saham ing taun lumaku 23andMe Holding Co|Psychemedics Corp - Wutah bathi ing taun lumaku
